| Application no. and date | 14725816.4 (espacenet) (Federated) (European Patent Register), 20140314 | | Patent/reg. no. and date | DK/EP 2968477, 20191204 | | Publication date | 20160120 | | Priority no. and date | US 201361800293 P, 20130315, US 201361817085 P, 20130429, US 201361829884 P, 20130531, US 201361839477 P, 20130626, US 201361863860 P, 20130808, US 201361876927 P, 20130912, US 201361879955 P, 20130919, US 201361897742 P, 20131030 | | EP pub. no. and date |
EP 2968477 20160120 | | Effective date | | | Applicant/owner | Bioverativ Therapeutics Inc., 225 Second Avenue
Waltham, MA 02451, US | | Applicant ref. no. | 1542267 | | Inventor | MALONEY, Kevin, 14 Cambridge Center
Cambridge, Massachusetts 02142, US,
ABDUL-FATTAH, Ahmad, 14 Cambridge Center
Cambridge, Massachusetts 02142, US,
GAGE, Daniel, 14 Cambridge Center
Cambridge, Massachusetts 02142, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/37 (2006.01) | | Title | FAKTOR VIII-POLYPEPTIDFORMULERINGER | | Int. application no. | US2014029354 | | Int. publication no. | WO2014144795 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
